Pulmonary Function Testing Systems Market is valued at USD 508.0 Million in 2021 and is expected to reach USD 776.1 Million by 2028 with a CAGR of 6.64% over the forecast period.
Increasing prevalence of respiratory diseases, growth in the elderly population and the rising prevalence of lung cancer are the major drivers propelling market growth.
Market Analysis of Pulmonary Function Testing Systems:-
Pulmonary function tests (PFTs) are noninvasive tests that show how well the lungs are working. Pulmonary function tests system consists of a series of tests to determine and measure the effectiveness of pulmonary inhalation and exhalation functions. It can diagnose certain types of lung diseases such as asthma, bronchitis and emphysema, as well as determine the cause of shortness of breath.
Download Free Exclusive Sample (200 Pages PDF) Report @ :
Pulmonary Function Testing Systems Companies-
Global pulmonary function testing systems market report covers prominent players like CareFusion(BD), Schiller, CHEST, COSMED, nSpire Health, NDD, MGC Diagnostics, Minato, Ganshorn, AESRI, Morgan Scientific, and among others.
Pulmonary Function Testing Systems Market Segmentation:-
Complete PFT Systems
Portable PFT Systems
By Test Type:
Gas Exchange Testing
Maximal Voluntary Ventilation
Oxygen Titration Test
High Altitude Simulation Testing
Chronic Obstructive Pulmonary Disease
Chronic Shortness of Breath
Restrictive Lung Disease
Increasing incidences of lung cancer, as well as other chronic lung-related diseases, is the main factor driving the growth of the global pulmonary function testing systems market. According to the American Cancer Society, in the United States around 228,150 new cases of lung cancer occur in 2019. Additionally, around 142,670 deaths occur from lung cancer (76,650 in men and 66,020 in women).
North America is expected to account for the largest share of the pulmonary function testing systems market during the forecast period. This is attributed to the rising technological advancements in diagnostics, coupled with the increasing prevalence of respiratory diseases and other pulmonary disorders.
The European market for pulmonary function testing systems is expected to be the second-largest during the forecast period owing to the increasing prevalence of lung diseases such as asthma, COPD, and the increasing demand for lung function tests in this region. According to European Respiratory Journal, in Europe, almost 10? billion people <45?years of age have asthma. The prevalence of asthma in the European Union (EU) is 8.2% in adults and 9.4% in children. Asia-Pacific is estimated to be the fastest-growing market due to the increasing demand for pulmonary function testing devices in private hospitals and clinics.
Key Benefits for Pulmonary Function Testing Systems Market Report–
Global Market report covers in-depth historical and forecast analysis.
Global Market research report provides detailed information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
Global Market report helps to identify opportunities in the market place.
Global Market report covers extensive analysis of emerging trends and competitive landscape.
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact No.: +91 7447409162, +44-2038074155, 1-888-853-7040
Email: [email protected]